WeVote

Bill

Bill

HB 1881

Adds xylazine to the list of Schedule III controlled substances

2026 Regular Session Introduced by Bill Allen and 3 co-sponsors

Missouri bill reclassifies xylazine as a Schedule III controlled substance, criminalizing possession and distribution to address rising street drug abuse.

Dropped from Calendar - Pursuant to House Rules (H)
0
WeVote Research Nonpartisan
Bill Summary · HB 1881

Legislative bill overview

HB 1881 reclassifies xylazine, a veterinary sedative increasingly used as a street drug, from an unscheduled substance to a Schedule III controlled substance in Missouri. This places xylazine alongside other regulated drugs with moderate abuse potential and establishes criminal penalties for unauthorized possession and distribution.

Why is this important

Xylazine has become a significant public health concern, often mixed with fentanyl and heroin, complicating overdose response and treatment. Scheduling it as a controlled substance gives law enforcement legal tools to address its distribution while signaling state recognition of an emerging drug threat that has particularly impacted rural and urban communities.

Potential points of contention

  • Treatment vs. criminalization: Scheduling may increase criminal charges for users rather than directing them toward addiction treatment, potentially worsening substance use disorder outcomes
  • Medical use restrictions: Schedule III classification limits legitimate veterinary and research applications, potentially affecting animal care providers and scientific research
  • Enforcement burden: Creates new charges for law enforcement and courts without necessarily addressing why xylazine use is increasing or providing additional treatment resources

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.